Primary diffuse large B-cell lymphoma of endometrium

Yuqing Zou, Hongmin Zhao, Jianhua Gao, Hong Zhu, Yong Li, Jianhua Zheng

Abstract


This article was designed to analyze the prognosis and to explore the clinical characteristics and treatment of a case of primary diffuse large B-cell lymphoma (DLBCL) of the endometrium, through a detailed report. Methods: This report was done by analyzing a case through its clinical features, pathological examination and immunophenotyping. We believe that this would allow us to forecast the prognosis of the case. Case Description: The patient was admitted because of irregular postmenopausal vaginal bleeding for more than a month. She underwent a series of surgical procedures that included abdominal hysterectomy, bilateral adnexectomy, pelvic lymph node dissection and enterolysis owing to the assessed pathological results after uterine curettage. The postoperative pathological results showed that it was a DLBCL. Conclusion: Primary DLBCL of the endometrium is rarely reported. Its diagnosis and differential diagnosis mainly depends on pathological examination and immunophenotyping. Radical surgery combined with chemotherapy may be an ideal mode of treatment. The prognosis of the disease has a varied range but radical surgery combined with chemotherapy may improve her quality of life and prolong her survival period.

Keywords


endometrial cancer; diffuse large B cell lymphoma; non Hodgkin lymphoma (NHL)

Full Text:

PDF

References


Farid KI. Lymphomas of the female genital tract: a study of 186 cases and review of the literature. The American Journal of Surgical Pathology 2005;29(11):1512–1520. doi: 10.1097/01.pas.0000178089.77018.a9

Fox H, More JRS. Primary malignant lymphoma of the uterus. Journal of Clinical Pathology 1965;18:723. doi: 10.1136/jcp.18.6.723

Fisher RI, Miller TP, O’Connor OA. Diffuse aggressive lymphoma. Hematology Am Soc Hematol Educ Program 2004;221–236. doi: 10.1182/asheducation-2004.1.221

Zou H, Fu J. Advances of primary lymphoma in the female genital system. Journal of Practical Obstetrics and Gynecology 2011;5:339–341.

Qing XY, Yao WX, Xu YQ. Prospect on research and development of B-DLCL. Chinese Journal of Clinicians (Electronic Edition) 2012;6:983–985.

Cheng H, Zhang B, Xie Y, et. al. Two cases of uterine B-DLCL. Chinese Journal of Clinicians (Electronic Edition) 2013;7(3):1352–1353.

Wang LY, Su LP, Guo YR. One case of primary ureteral lymphoma and review of the literature. Journal of Leukemia & Lymphoma 2010;19:244–245.

Linzer DL, Levine AJ. Characterization of a 54K Dalton cellular SV40 tumor antigen present in SV40-transformed cells and uninfected embryonal carcinoma cells. Cell 1979;17(1):43–45. doi: 10.1016/0092-8674(79)90293-9

Ozaki K, Yamagami T, Nomura K, et. al. Prognostic significance of surgical margin, Ki-67 and cyclin D1 protein expression in grade II canine cutaneous mast cell tumor. Vet Med Sci 2007;69(11):1117–1121. doi: 10.1292/jvms.69.1117

Wen HQ, Geng YY, Hu HJ et. al. Expression of Bc1-2 and Ki-67 in the endometria diseases. Chinese Clinical Oncology 2009;14(7):614–618.

Yoon DH, Choi DR, Ahn HJ et .al. Ki-67 expression as a prognostic factor in diffuse large B-cell lymphoma patients treated with rituximab plus CHOP. Eur J Haematol 2010;85:149–157.

Jones SE, Miller TP, Connors JM. Long-term follow-up and analysis for prognostic factors for patients with limited stage diffuse large-cell lymphoma treated with initial chemotherapy with or without adjuvant radiotherapy. J Clin Oncol 1989;7(9):1186–1191.

Zhang LJ, Wang FW. Progress of diffuse large B cell lymphoma. Chinese Journal of Clinicians (Electronic Edition) 2014;8(11):2127–2132.




DOI: http://dx.doi.org/10.30564/amor.v1i1.7

Refbacks

  • There are currently no refbacks.


Copyright (c) 2018 Yuqing Zou, Hongmin Zhao, Jianhua Gao, Hong Zhu, Yong Li, Jianhua Zheng

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.